USAIC’s 19th Annual BioPharma Summit
Organized by USAIC
May 6, 2025
The Newbury Boston Hotel, Boston, Massachusetts

Chair & Emcee: Dr. Andrew Plump, President of R&D, Takeda Pharmaceuticals

Super Session: Honoring Dr. Stelios Papadopoulos, Chair of the Board, Exelixis, Inc. with the Distinguished Service Award

Participants & Speakers Include:

Alan Garber, President, Harvard University; Chris Viehbacher, CEO, Biogen; Hari Bhartia, Founder & Co-Chairman, Jubilant Bhartia Group; Francesco De Rubertis, Co-Founder, Medicxi; Rajiv Kaul, Sector Portfolio Manager, Fidelity Investments; Sanat Chattopadhyay, President, Merck Manufacturing Division, Merck & Co; Kris Jenner, Managing Member, Rock Springs Capital; Susan Hockfield, President Emerita, MIT; Nancy Andrews, Chief Scientific Officer, Boston Children’s Hospital; Stephen Knight, Managing Partner, F-Prime Capital; Sarah Sheikh, Head of Global Dev, Takeda; Steve Harr, CEO, Sana Biotechnology; Daphne Zohar, Founder & CEO, Seaport Therapeutics; Dina Katabi, Prof. of Computer Science, MIT; Priya Singhal, Head of Dev, Biogen; Sastry Chilukuri, Chairman, Emmes Group; Najat Khan, Chief R&D Officer, Recursion; Hans-Juergen Woerle, CSMO, Nestlé Health Science; Christoph Koenen, Head Clinical Dev, Bayer Consumer Care; Peyton Howell, CEO, Parexel; Fiona Elwood, VP Neuroscience, J&J Innovative Medicine; Parag Saxena, Co-Founder, Vedanta Capital; Sam Waksal, CEO, Graviton; Mathai Mammen, Chairman & CEO, Parabilis Medicines; Alexandria Forbes, CEO, MeiraGTx; Prem Lachman, Managing Partner, Maximus Capital; Michael Morrissey, CEO, Exelixis; Paul Peter Tak, CEO, Candel Therapeutics; Claire Mazumdar, CEO, Bicara; Belen Fraile, Chief R&D Data Science Officer, J&J Innovative Medicine; Maria Freire, ex FNIH; Philip Larsen, CEO, Six Peaks Bio; Fred Chereau, SVP, Alexion; Nabiha Saklayen, CEO, Cellino; Jeb Keiper, ex  CEO, Nimbus; Tim Harris, Operating Partner, SV Health Investors; Harith Rajagopalan, CEO, Fractyl; Stephen Uden, CEO, Rallybio; Fawzi Benzaghou, Head Oncology R&D, IPSEN; Paul Sekhri, CEO, vTv Therapeutics, Jeff Spaeder, Chief Medical & Scientific Officer, IQVIA

Panel Discussions and Fireside Chats Covering:

• Oncology
• Value & Access
• Rare & Neuro Diseases
• R&D Strategies and Trends
• Industry Academic Partnerships
• Clinical Trials Opportunities in India
• Digital & Data Science in Healthcare
• BioPharma Investment Priorities & Industry Outlook

Strategy Sessions (by invitation only):

• Digital & Data Sciences
• External Research & Clinical Trials